Immunogen-grade expansion Athens Bioscience recently launched an immunogen-grade protein line verified for purity and composition by mass spectrometry, signaling an opportunity to upsell to customers requiring high-purity native proteins for diagnostics, translational research, and regulatory submissions.

Native protein focus Position the company as a specialized supplier of native human and animal proteins with consistent sourcing, lot-to-lot reproducibility, and a single-site, ISO 9001:2015-certified quality system to win contracts from IVD developers and cell culture media companies seeking strict quality control.

End-to-end control Emphasize 100 percent in-house production and traceable chain of custody to prospective buyers that require qualification audits, regulatory filings, and auditable supply chains, presenting Athens as a low-risk manufacturing partner for compliant proteomics workflows.

Scale flexibility Highlight capability to service both mg-scale research orders and kg-scale commercial production, offering scalable protein manufacturing with consistent processes and professional support for customers planning pilots, validations, or large-scale deployments.

Strategic partnerships Leverage the track record of 2,500+ peer-reviewed citations and existing broadcast among IVD developers, media formulators, and life science researchers to approach potential customers in related spaces such as diagnostic calibrator suppliers, media companies, and biotech research tool providers for collaboration or contract manufacturing.